RVPH: Reviva Pharmaceuticals Holdings Inc. Stocks News on June 2, 2025

Reviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

RVPH

GlobeNewswire

8 hours ago

Reviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

RVPH

Zacks Small Cap Research

11 days ago

RVPH: 1Q:25 Results

Reviva to Participate in Upcoming Investor Conferences in May 2025

RVPH

GlobeNewswire

13 days ago

Reviva to Participate in Upcoming Investor Conferences in May 2025

Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights

RVPH

GlobeNewswire

18 days ago

Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights

Reviva to Participate in the A.G.P. Healthcare Company Showcase

RVPH

GlobeNewswire

20 days ago

Reviva to Participate in the A.G.P. Healthcare Company Showcase

Reviva to Participate in the Citizens Life Sciences Conference

RVPH

GlobeNewswire

a month ago

Reviva to Participate in the Citizens Life Sciences Conference

Reviva to Present Late-Breaking Poster on the RECOVER Long-term Open Label Extension Trial for Brilaroxazine in Schizophrenia at the 2025 ASCP Annual Meeting

RVPH

GlobeNewswire

a month ago

Reviva to Present Late-Breaking Poster on the RECOVER Long-term Open Label Extension Trial for Brilaroxazine in Schizophrenia at the 2025 ASCP Annual Meeting

RVPH

Zacks Small Cap Research

2 months ago

RVPH: M&A Deals Highlight Brilaroxazine Value

Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights

RVPH

GlobeNewswire

2 months ago

Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights

Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress

RVPH

GlobeNewswire

2 months ago

Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress

Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

RVPH

GlobeNewswire

4 months ago

Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Reviva to Participate in the 2025 BIO CEO & Investor Conference

RVPH

GlobeNewswire

4 months ago

Reviva to Participate in the 2025 BIO CEO & Investor Conference

Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit

RVPH

GlobeNewswire

5 months ago

Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit

RVPH

Zacks Small Cap Research

5 months ago

RVPH: Preliminary OLE Readout

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

RVPH

GlobeNewswire

5 months ago

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

Reviva Pharmaceuticals Strengthens Financial Position with Offering

RVPH

TipRanks

5 months ago

Reviva Pharmaceuticals Strengthens Financial Position with Offering

RVPH

MT Newswires

6 months ago

Top Midday Decliners

RVPH

MT Newswires

6 months ago

Reviva Pharmaceuticals Prices $18 Million Public Offering

Reviva Announces Proposed Public Offering

RVPH

GlobeNewswire

6 months ago

Reviva Announces Proposed Public Offering

RVPH

MT Newswires

6 months ago

Reviva Pharmaceuticals Reports Positive Topline Phase 3 Data on Brilaroxazine for Treating Schizophrenia

Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia

RVPH

GlobeNewswire

6 months ago

Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia

RVPH

Zacks Small Cap Research

6 months ago

RVPH: Year-End OLE Update

Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights

RVPH

GlobeNewswire

7 months ago

Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

RVPH

GlobeNewswire

7 months ago

Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024

RVPH

GlobeNewswire

7 months ago

Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024

Reviva to Participate in the UBS Global Healthcare Conference

RVPH

GlobeNewswire

7 months ago

Reviva to Participate in the UBS Global Healthcare Conference

Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit

RVPH

GlobeNewswire

8 months ago

Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit

Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

RVPH

GlobeNewswire

8 months ago

Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference

RVPH

GlobeNewswire

8 months ago

Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference

RVPH

Zacks Small Cap Research

9 months ago

RVPH: RECOVER Biomarker KOL Event

Reviva Announces New Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

RVPH

GlobeNewswire

9 months ago

Reviva Announces New Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

Reviva to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

RVPH

GlobeNewswire

9 months ago

Reviva to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Reviva to Host Virtual KOL Event to Discuss Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia on September 4, 2024

RVPH

GlobeNewswire

9 months ago

Reviva to Host Virtual KOL Event to Discuss Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia on September 4, 2024

RVPH

Zacks Small Cap Research

9 months ago

RVPH: August OLE Update

RVPH

MT Newswires

9 months ago

Top Midday Decliners

RVPH

MT Newswires

9 months ago

Reviva Pharmaceuticals Holdings Prices $5 Million Offering

Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules

RVPH

GlobeNewswire

9 months ago

Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules

Reviva Reports Second Quarter 2024 Financial Results and Recent Business Highlights

RVPH

GlobeNewswire

10 months ago

Reviva Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Reviva Announces Grant of U.S. Patent Covering Use of Brilaroxazine for the Treatment of Idiopathic Pulmonary Fibrosis

RVPH

GlobeNewswire

10 months ago

Reviva Announces Grant of U.S. Patent Covering Use of Brilaroxazine for the Treatment of Idiopathic Pulmonary Fibrosis

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

RVPH

GlobeNewswire

a year ago

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

RVPH

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

RVPH

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

RVPH

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

RVPH

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

RVPH

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

RVPH

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

RVPH

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

RVPH

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

RVPH

GlobeNewswire

a year ago

Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

RVPH

MT Newswires

a year ago

Riviva Pharmaceuticals Prices $3 Million Offering of Stock, Warrants; Shares Slump

Reviva Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

RVPH

GlobeNewswire

a year ago

Reviva Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

RVPH

Zacks Small Cap Research

a year ago

RVPH: Enrollment Right Around the Corner

Reviva to Participate in the BIO International Convention

RVPH

GlobeNewswire

a year ago

Reviva to Participate in the BIO International Convention

RVPH

GlobeNewswire

a year ago

Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights

RVPH

GlobeNewswire

a year ago

Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights

Reviva to Present New Preclinical Efficacy Data on Brilaroxazine in Idiopathic Pulmonary Fibrosis at 2024 ATS International Conference

RVPH

GlobeNewswire

a year ago

Reviva to Present New Preclinical Efficacy Data on Brilaroxazine in Idiopathic Pulmonary Fibrosis at 2024 ATS International Conference

Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting

RVPH

GlobeNewswire

a year ago

Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting

RVPH

Zacks Small Cap Research

a year ago

RVPH: Full Year 2023 Results

Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia

RVPH

GlobeNewswire

a year ago

Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia

Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights

RVPH

GlobeNewswire

a year ago

Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights

RVPH

Zacks Small Cap Research

a year ago

RVPH: Update to Brilaroxazine Safety vs. Efficacy Comparison – Adding RECOVER Data

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the SIRS 2024 Annual Meeting

RVPH

GlobeNewswire

a year ago

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the SIRS 2024 Annual Meeting

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting

RVPH

GlobeNewswire

a year ago

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting

Reviva to Present at the UBS Virtual CNS Day

RVPH

GlobeNewswire

a year ago

Reviva to Present at the UBS Virtual CNS Day

Reviva to Present at the 36th Annual ROTH Conference

RVPH

GlobeNewswire

a year ago

Reviva to Present at the 36th Annual ROTH Conference

Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

RVPH

GlobeNewswire

a year ago

Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

Reviva to Host KOL Event to Discuss Topline Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

RVPH

GlobeNewswire

a year ago

Reviva to Host KOL Event to Discuss Topline Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

RVPH

Thomson Reuters StreetEvents

a year ago

Q1 2024 DLH Holdings Corp Earnings Call

DLH Holdings Corp Reports Notable Revenue Growth and EBITDA Expansion in Q1 Fiscal 2024

RVPH

GuruFocus.com

a year ago

DLH Holdings Corp Reports Notable Revenue Growth and EBITDA Expansion in Q1 Fiscal 2024

New Pacific Metals Announces 2024 Plans for Operations in Bolivia

RVPH

PR Newswire

a year ago

New Pacific Metals Announces 2024 Plans for Operations in Bolivia

DLH Reports Fiscal 2024 First Quarter Results

RVPH

GlobeNewswire

a year ago

DLH Reports Fiscal 2024 First Quarter Results

Carter Bankshares, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

RVPH

ACCESSWIRE

a year ago

Carter Bankshares, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference

RVPH

GlobeNewswire

a year ago

Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference

Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs

RVPH

InvestorPlace

a year ago

Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs

LuxUrban Hotels Inc. (NASDAQ:LUXH) Has Found A Path To Profitability

RVPH

Simply Wall St.

a year ago

LuxUrban Hotels Inc. (NASDAQ:LUXH) Has Found A Path To Profitability

Investors in BV Financial (NASDAQ:BVFL) have unfortunately lost 47% over the last year

RVPH

Simply Wall St.

a year ago

Investors in BV Financial (NASDAQ:BVFL) have unfortunately lost 47% over the last year

Union Bankshares Inc Reports Decline in Quarterly and Annual Earnings for 2023

RVPH

GuruFocus.com

a year ago

Union Bankshares Inc Reports Decline in Quarterly and Annual Earnings for 2023

SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India

RVPH

PR Newswire

a year ago

SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India

Reviva to Present at Webull LIVE! Healthcare Webinar on January 17

RVPH

ACCESSWIRE

a year ago

Reviva to Present at Webull LIVE! Healthcare Webinar on January 17

Therapy’s New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution

RVPH

InvestorPlace

a year ago

Therapy’s New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution

3 Big New Catalysts for Psychedelics Stocks in 2024

RVPH

Motley Fool

a year ago

3 Big New Catalysts for Psychedelics Stocks in 2024

Steel Partners Holdings L.P. Announces Extension of Effective Date for Reverse/Forward Unit Split

RVPH

Business Wire

a year ago

Steel Partners Holdings L.P. Announces Extension of Effective Date for Reverse/Forward Unit Split

4 Top-Ranked Stocks With Solid Net Profit Margin to Buy Now

RVPH

Zacks

a year ago

4 Top-Ranked Stocks With Solid Net Profit Margin to Buy Now

Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference

RVPH

GlobeNewswire

a year ago

Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference

1 Unstoppable Stock Down 21% You'll Wish You'd Bought on the Dip in 2024

RVPH

Motley Fool

a year ago

1 Unstoppable Stock Down 21% You'll Wish You'd Bought on the Dip in 2024

Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies

RVPH

GlobeNewswire

a year ago

Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies

RVPH

Zacks

a year ago

Visa (V) Enhances Customer Experience With New Loyalty Solution

CORRECTION - Alpine Income Property Trust Announces 2023 Transaction Activity and Provides Corporate Update

RVPH

GlobeNewswire

a year ago

CORRECTION - Alpine Income Property Trust Announces 2023 Transaction Activity and Provides Corporate Update

Voyager Therapeutics Announces Proposed Public Offering

RVPH

GlobeNewswire

a year ago

Voyager Therapeutics Announces Proposed Public Offering

Alpine Income Property Trust Announces 2023 Transaction Activity and Provides Corporate Update

RVPH

GlobeNewswire

a year ago

Alpine Income Property Trust Announces 2023 Transaction Activity and Provides Corporate Update

RVPH

Reuters

a year ago

Trading volumes for sugar, coffee and cocoa sharply up in 2023 - ICE

Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones

RVPH

GlobeNewswire

a year ago

Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones

RCM Technologies, Inc.'s (NASDAQ:RCMT) largest shareholders are retail investors with 33% ownership, institutions own 28%

RVPH

Simply Wall St.

a year ago

RCM Technologies, Inc.'s (NASDAQ:RCMT) largest shareholders are retail investors with 33% ownership, institutions own 28%

Strong gains for cocoa, iron ore in 2023 as energy prices dip

RVPH

Reuters

a year ago

Strong gains for cocoa, iron ore in 2023 as energy prices dip

Smith-Midland Appoints New Members to its Board of Directors

RVPH

ACCESSWIRE

a year ago

Smith-Midland Appoints New Members to its Board of Directors

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

RVPH

The Fly

a year ago

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

G. WILLI-FOOD ANNOUNCES SHARE REPURCHASE PROGRAM

RVPH

PR Newswire

a year ago

G. WILLI-FOOD ANNOUNCES SHARE REPURCHASE PROGRAM

Owning 44% shares,institutional owners seem interested in Smith-Midland Corporation (NASDAQ:SMID),

RVPH

Simply Wall St.

a year ago

Owning 44% shares,institutional owners seem interested in Smith-Midland Corporation (NASDAQ:SMID),

NuScale Appoints Fluor’s Jim Breuer to Board of Directors

RVPH

Business Wire

a year ago

NuScale Appoints Fluor’s Jim Breuer to Board of Directors

Gilead (GILD), Compugen Collaborate for Immunotherapy Program

RVPH

Zacks

a year ago

Latest Reviva Pharmaceuticals Holdings Inc. (RVPH) News on June 2, 2025

Share on Social Networks: